C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/1998
12/23/1998	EP0885965A2 Histidine kinase polypeptides
12/23/1998	EP0885963A2 Compounds comprising polypeptides and polynucleotides of Streptococcus pneumoniae,said polypeptides being related by amino acid sequence homology to SapR from Streptococcus mutans polypeptide
12/23/1998	EP0885960A2 G-protein coupled receptor (H7TBA62)
12/23/1998	EP0885959A2 Human Wnt-5b protein
12/23/1998	EP0885956A1 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro) biological production of proteins
12/23/1998	EP0885903A2 Nucleic acid encoding streptococcus pheumoniae response regulator
12/23/1998	EP0885902A2 Nucleic acid encoding Streptococcus pneumoniae response regulator
12/23/1998	EP0885901A2 Nucleic acid encoding Streptococcus pneumoniae response regulator
12/23/1998	EP0885614A2 Method of ex vivo immunizing using heterologous intact bispecific and/or trispecific antibodies
12/23/1998	EP0885393A1 Graphitic nanotubes in luminescence assays
12/23/1998	EP0885301A1 Down-regulation resistant c3 convertase
12/23/1998	EP0885299A1 Wsx receptor and ligands
12/23/1998	EP0885297A1 Novel era
12/23/1998	EP0885244A1 Peptide immunogens for vaccination against and treatment of allergy
12/23/1998	EP0885046A1 Filtration of plasma mixtures using cellulose-based filter aids
12/23/1998	EP0885012A1 Malaria vaccine based upon the addition of a msa1 peptide
12/23/1998	EP0787300B1 Stabilising medium for alpha-gst in urine for use in an enzyme immunoassay
12/23/1998	EP0648276B1 Monoclonal antibodies to glycoprotein p
12/23/1998	EP0607222B1 Dendrimeric polychelants
12/23/1998	EP0541629B1 Cloning and expression of a rhoptry associated protein of (p.falciparum)
12/23/1998	EP0473721B1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
12/23/1998	CN1202932A Therapeutic antiangiogenic compositions and methods
12/23/1998	CN1202905A Parainfluenza virus glycoproteins and vaccines
12/23/1998	CN1202822A Use of a THF alpha antagonist for treating neurogenic skin redness
12/23/1998	CN1202496A Process for preparing refined vitelline antibody
12/23/1998	CN1041326C Process for preparing CAV nucleic acid series and amino acid series
12/23/1998	CA2295440A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof
12/23/1998	CA2295439A1 Mammalian neuro-growth factor like protein
12/23/1998	CA2295317A1 Heregulin-like factor
12/23/1998	CA2294563A1 New human lysophospholipase
12/23/1998	CA2294435A1 Human preprotachykinin b
12/23/1998	CA2293998A1 Irs-p53h, human insulin receptor tyrosine kinase substrate
12/23/1998	CA2293740A1 Apo-2dcr, a tnf-related receptor
12/23/1998	CA2293735A1 Lag-3 splice variants
12/23/1998	CA2293732A1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
12/23/1998	CA2292912A1 Therapeutic composition and method of treatment
12/23/1998	CA2287540A1 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity
12/22/1998	US5852186 Reactive neutralizing human anti-GP120 recombinant antibody, DNA coding the same and use thereof
12/22/1998	US5852184 Protein tyrosine kinase
12/22/1998	US5852183 Dog-mouse heterohybridoma and gene fragment coding for constant region of canine immunoglobulins
12/22/1998	US5852177 Basic fibroblast growth factor (bFGF) muteins
12/22/1998	US5852176 Antibodies to receptors for human interleukin-12
12/22/1998	US5852175 P-selectin glycoprotein ligand blocking antibodies
12/22/1998	US5852174 Antibodies to liver derived receptors for advanced glycosylation endproducts and uses therefor
12/22/1998	US5852173 TNF receptor death ligand proteins and inhibitors of ligand binding
12/22/1998	US5852170 ICAM-4 materials and methods
12/22/1998	US5852167 Totally synthetic affinity reagents
12/22/1998	US5852009 Compositions, including pharmaceutical compositions, for inhibiting the advanced glycosylation of proteins, and therapeutic methods based thereon
12/22/1998	US5851999 FLK-1 is a receptor for vascular endothelial growth factor
12/22/1998	US5851987 Human tumor-associated Kazal inhibitor-like polypeptides and encoding polynucleotides
12/22/1998	US5851830 Luminal epithelial antigen
12/22/1998	US5851829 Method of intracellular binding of target molecules
12/22/1998	US5851827 DNA encoding clostridium perfringens alpha-toxin peptides
12/22/1998	US5851814 Human elastate IV
12/22/1998	US5851809 Tryptophanyl tRNA Synthetase polynucleotides of Streptococcus
12/22/1998	US5851801 Method of preparing polypeptide binding compositions derived from immunoglobulin variable regions
12/22/1998	US5851798 Nucleic acid encoding human GPR14 receptor
12/22/1998	US5851795 Soluble CTLA4 molecules and uses thereof
12/22/1998	US5851793 Recombinant DNA encoding receptor protein for human B-cell stimulatory factor-2
12/22/1998	US5851791 Ubiquitin conjugating enzyme (E2) fusion proteins
12/22/1998	US5851787 Nucleic acid encoding amyloid precursor-like protein and uses thereof
12/22/1998	US5851784 Human phosphodiesterase type IVC, and its production and use
12/22/1998	US5851781 Reagents and methods for the detection and quantification of testosterone in fluid samples
12/22/1998	US5851778 Analyte assay using a trifunctional conjugate
12/22/1998	US5851764 Human prostate tumor inducing gene-1 and uses thereof
12/22/1998	US5851528 Methods of inhibiting complement activation
12/22/1998	US5851526 Methods of treating colon cancer utilizing tumor-specific antibodies
12/22/1998	US5851525 Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
12/22/1998	US5851524 Human monoclonal anti-rhesus (D) antibodies and cell lines producing same
12/22/1998	US5851523 Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof
12/22/1998	CA2129219C Humanised antibodies
12/22/1998	CA1340282C Atrial natriuretic/vasodilator polypeptides
12/22/1998	CA1340281C Process for preparing and purifying alpha-interferon
12/20/1998	CA2676074A1 Chromatographic method for high yield purification and viral inactivation of antibodies
12/20/1998	CA2235444A1 Novel compounds
12/20/1998	CA2235442A1 Response regulator
12/20/1998	CA2235441A1 Novel compounds
12/20/1998	CA2235437A1 Novel compounds
12/20/1998	CA2235435A1 Novel compounds
12/20/1998	CA2235433A1 Novel compounds
12/20/1998	CA2235422A1 Novel compounds
12/18/1998	CA2239605A1 Novel g-protein coupled receptor (h7tba62)
12/17/1998	WO1998056951A1 Reagents and methods useful for detecting diseases of the lung
12/17/1998	WO1998056928A1 Increased production of proteins by using chaperone-like proteins
12/17/1998	WO1998056925A1 Human protein phosphatase ii-c-like protein
12/17/1998	WO1998056924A1 Prenylcysteine carboxyl methyltransferase, dna encoding same, and a method of screening for inhibitors thereof
12/17/1998	WO1998056915A2 Artificial antibody polypeptides
12/17/1998	WO1998056913A1 Smad6 and uses thereof
12/17/1998	WO1998056911A1 Human phosphatidylinositol transfer protein gamma
12/17/1998	WO1998056910A1 DETECTION OF LOSS OF THE WILD-TYPE huBUB1 GENE
12/17/1998	WO1998056907A1 Heart and skeleton muscle specific nucleic acid, the production and use thereof
12/17/1998	WO1998056906A1 Trimerising module
12/17/1998	WO1998056822A2 Process for the separation of specific immunoglobulins from standard plasma
12/17/1998	WO1998056820A1 Hm74a receptor
12/17/1998	WO1998056818A1 Human l105 proteins and polynucleotides encoding same
12/17/1998	WO1998056808A1 Protein recovery by chromatography followed by filtration upon a charged layer
12/17/1998	WO1998056419A1 Methods of delaying development of hmfg-associated tumors using anti-idiotype antibody 11d10
12/17/1998	WO1998056418A1 Stabilized antibody formulation
12/17/1998	WO1998056417A1 Composition and method to prevent graft rejection and other counter-adaptive t lymphocyte mediated immune responses
12/17/1998	WO1998056416A1 Immunogenic compositions for induction of anti-tumor immunity

1 ... 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 ... 1494